Guangdong Jiaying Pharmaceutical Co., Ltd

¥3.19As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002198Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (12.40%)
Div yield —
ROE 1.46%
Drug Manufacturers (General)
Beta (5Y) 0.07
PE TTM 155.7
TSR TTM (51.22%)
Mkt cap ¥1.586B
ROIC 3.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.44
7.82%
(66.45%)
Hold 11|9|10|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.07
0.07
0.07
13.52%
26.27%
21.88%
22.67%
Revenue¥M
91.92
96.85
93.96
99.36
5.44%
10.62%
9.76%
14.49%
Peers (US$237.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.682
—
—
EBIT/Intx
0.576
0.528
0.471
Own earn%
19.43
(84.23)
(79.83)
Sh yield%
16.16
20.53
22.64
Owners
Insiders/Inst%
5.46
56.76
Short interest%
2.84
SBC / revenue%
0.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
47